Caspase Recruitment Domain Family Member 8: A Favorable Target in the Pathogenesis of Atherosclerosis

Area of Science:

• Immunology
• Cardiovascular Biology
• Molecular Medicine

Background:

• Atherosclerosis is a chronic inflammatory disease driven by lipid accumulation and immune cell infiltration.
• The NOD-like Receptor Pyrin Domain-Containing 3 (NLRP3) inflammasome is a critical mediator of inflammation in atherosclerosis.
• Caspase recruitment domain family member 8 (CARD8) is identified as a key regulator of NLRP3 inflammasome activity.

Purpose of the Study:

• To review the current understanding of CARD8's role in atherosclerosis pathogenesis.
• To highlight CARD8's regulatory effects on immune cells and inflammatory pathways.
• To explore the therapeutic potential of targeting CARD8 for atherosclerosis treatment.

Main Methods:

• Literature review of recent preclinical and clinical studies.
• Analysis of CARD8's influence on lipid accumulation, oxidative stress, and vascular inflammation.
• Examination of CARD8's impact on smooth muscle cell proliferation and plaque stability.

Main Results:

• CARD8 modulates NLRP3 inflammasome activity, influencing key aspects of atherosclerotic development.
• Evidence suggests CARD8 impacts lipid deposition, oxidative stress, and vascular inflammation.
• CARD8 plays a role in smooth muscle cell proliferation and atherosclerotic plaque instability.

Conclusions:

• CARD8 is a significant regulator in atherosclerosis, impacting multiple pathological processes.
• Targeting CARD8 presents a promising therapeutic avenue for managing atherosclerosis.
• Further research into CARD8-targeted therapies is warranted based on existing evidence.